Eliminación de las pautas de repetición del tratamiento de categoría II de las directrices del Programa Nacional Contra la Tuberculosis: el caso de Georgia
Jennifer Furin, Iagor Kalandadze(National Center for Tuberculosis and Lung Disease), Rocio Hurtado(Harvard University), Jacob Joseph(Lourdes Hospital), Carole D. Mitnick(Brigham and Women's Hospital), Michael Rich, Medea Gegia(World Health Organization), Peter Drobac(University of Oxford), Sonya Shin(Brigham and Women's Hospital), Mercedes C. Becerra(Brigham and Women's Hospital), Paul Farmer(Harvard University), Salmaan Keshavjee(Brigham and Women's Hospital)
Cited by 0
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Structural Violence and Clinical Medicine
|PLoS Medicine|2006|1.1k
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639